NCT04948970 is a clinical trial in Adrenal Disease, sponsored by Seoul National University Hospital.

Who is sponsoring NCT04948970?

NCT04948970 is sponsored by Seoul National University Hospital.

What condition does NCT04948970 study?

NCT04948970 studies Adrenal Disease.

Is NCT04948970 still recruiting?

NCT04948970 is currently completed. Last updated 23 January 2024.

Last reviewed 2024-01-23 · How we verify

NCT04948970

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Steroid Panel for One-step Diagnosis of Adrenal Diseases

Completed Last updated 23 January 2024

What this trial tests

trial in Adrenal Disease in 400 participants. Completed in 31 December 2023.

Timeline

21 June 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	400
Start date	21 June 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across South Korea

Conditions studied

Adrenal Disease — all drugs for Adrenal Disease →

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Adrenal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to develop a one-step diagnostic method for adrenal diseases, Patients with adrenal diseases including non-functioning adrenal adenoma, adrenal Cushing's syndrome, primary aldosteronism, and pheochromocytoma will be recruited. Using mass spectrometry analysis based on a multisteroid panel, serum, urine, saliva, and hair samples of the patients will be analyzed. The diagnostic yield of each and combination of steroids will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adrenal Disease

Currently open trials in the same condition.

NCT07191951 — Shanghai Clinical Cohort - Adrenal Disease · recruiting
NCT06050057 — Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04948970 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 23 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04948970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing